{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:08:06Z","timestamp":1784236086813,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"I declare no funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10320-7","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:27:53Z","timestamp":1771532873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer: review of the literature"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-340X","authenticated-orcid":false,"given":"Fausto","family":"Meriggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cherri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Gavezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bna\u2032","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zaniboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"10320_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025). Cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 75, 10\u201345.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10320_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0970-2113.71934","volume":"27","author":"VS Attili","year":"2010","unstructured":"Attili, V. S., Babu, K. G., Lokanatha, D., et al. (2010). Peritoneal carcinomatosis in lung cancer. Lung India, 27, 193\u2013195.","journal-title":"Lung India"},{"key":"10320_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2016.03.006","volume":"95","author":"KJ Suh","year":"2016","unstructured":"Suh, K. J., Kim, S. H., Lee, J. Y., et al. (2016). Peritoneal carcinomatosis in lung cancer: A single-institution retrospective analysis. Lung Cancer, 95, 82\u201387.","journal-title":"Lung Cancer"},{"key":"10320_CR4","first-page":"1247","volume":"17","author":"L Bertolaccini","year":"2021","unstructured":"Bertolaccini, L., Solli, P., Pardolesi, A., et al. (2021). Isolated peritoneal carcinomatosis from NSCLC: A rare but emerging entity. Future Oncology, 17, 1247\u20131250.","journal-title":"Future Oncology"},{"key":"10320_CR5","first-page":"2385","volume":"145","author":"S Su","year":"2019","unstructured":"Su, S., Huang, C., Chen, M., et al. (2019). Peritoneal carcinomatosis in lung cancer: A population-based study. Journal of Cancer Research and Clinical Oncology, 145, 2385\u20132392.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10320_CR6","first-page":"796","volume":"23","author":"V Calvo","year":"2021","unstructured":"Calvo, V., Vilari\u00f1o, N., S\u00e1nchez-Torres, J. M., et al. (2021). Clinical features and outcome of peritoneal carcinomatosis in lung cancer. Clinical and Translational Oncology, 23, 796\u2013802.","journal-title":"Clinical and Translational Oncology"},{"key":"10320_CR7","first-page":"287","volume":"50","author":"A Yoshimoto","year":"2006","unstructured":"Yoshimoto, A., Kasahara, K., Kawashima, A., et al. (2006). Autopsy findings in 1,000 cases of primary lung cancer. Lung Cancer, 50, 287\u2013291.","journal-title":"Lung Cancer"},{"key":"10320_CR8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1378\/chest.127.3.731","volume":"127","author":"H Sakurai","year":"2005","unstructured":"Sakurai, H., Asamura, H., Watanabe, S., et al. (2005). Patterns of extrathoracic metastasis in resected stage I non-small cell lung cancer. Chest, 127, 998\u20131002.","journal-title":"Chest"},{"key":"10320_CR9","first-page":"121","volume":"149","author":"DH Lee","year":"2020","unstructured":"Lee, D. H., Lee, J. S., Lee, J. Y., et al. (2020). Patterns of failure after treatment with EGFR-TKIs: A new era of unusual metastases. Lung Cancer, 149, 121\u2013128.","journal-title":"Lung Cancer"},{"key":"10320_CR10","first-page":"284","volume":"11","author":"M Riudavets","year":"2022","unstructured":"Riudavets, M., Garc\u00eda-L\u00f3pez, P., Orozco-Morales, M., et al. (2022). Atypical metastases in lung cancer: Real-world patterns in the era of immunotherapy. Transl Lung Cancer Res, 11, 284\u2013295.","journal-title":"Transl Lung Cancer Res"},{"key":"10320_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.lungcan.2020.05.001","volume":"145","author":"G Rossi","year":"2020","unstructured":"Rossi, G., Gatti, G., Valli, R., et al. (2020). EGFR-mutated lung adenocarcinoma with peritoneal spread: A case series. Lung Cancer, 145, 93\u201398.","journal-title":"Lung Cancer"},{"key":"10320_CR12","first-page":"617","volume":"22","author":"K Takeuchi","year":"2009","unstructured":"Takeuchi, K., Yokose, T., Ishii, G., et al. (2009). Prospective radiologic-pathologic analysis of small lung adenocarcinomas using thin-section computed tomography: Prognostic implications of the presence of ground-glass opacity components. Modern Pathology, 22, 617\u2013622.","journal-title":"Modern Pathology"},{"key":"10320_CR13","first-page":"605","volume":"64","author":"SD Nathanson","year":"1984","unstructured":"Nathanson, S. D. (1984). Molecular mechanisms of cancer metastasis. Surgical Clinics of North America, 64, 605\u2013620.","journal-title":"Surgical Clinics of North America"},{"key":"10320_CR14","first-page":"366","volume":"61","author":"J Akimoto","year":"2013","unstructured":"Akimoto, J. (2013). Lymphatic spread in thoracic tumors. General Thoracic and Cardiovascular Surgery, 61, 366\u2013372.","journal-title":"General Thoracic and Cardiovascular Surgery"},{"key":"10320_CR15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcp\/93.6.731","volume":"93","author":"RE Nakhleh","year":"1990","unstructured":"Nakhleh, R. E., Gal, A. A., Urbanski, S. J., et al. (1990). Implantation metastases: A rare complication of thoracentesis. American Journal of Clinical Pathology, 93, 662\u2013664.","journal-title":"American Journal of Clinical Pathology"},{"key":"10320_CR16","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/curroncol30030224","volume":"30","author":"L Siragusa","year":"2023","unstructured":"Siragusa, L., Di Carlo, S., Fassari, A., et al. (2023). Therapeutic strategies and oncological outcome of peritoneal metastases from lung cancer: A systematic review and pooled analysis. Current Oncology, 30, 2928\u20132941.","journal-title":"Current Oncology"},{"key":"10320_CR17","first-page":"1305","volume":"8","author":"H Satoh","year":"2001","unstructured":"Satoh, H., Ishikawa, H., Yamashita, Y. T., et al. (2001). Peritoneal carcinomatosis in lung cancer patients. Oncology Reports, 8, 1305\u20131307.","journal-title":"Oncology Reports"},{"key":"10320_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1843.2008.01268.x","volume":"13","author":"HT Su","year":"2008","unstructured":"Su, H. T., Tsai, C. M., & Perng, R. P. (2008). Peritoneal carcinomatosis in lung cancer. Respirology, 13, 465\u2013467.","journal-title":"Respirology"},{"key":"10320_CR19","first-page":"586","volume":"16","author":"O Tanriverdi","year":"2012","unstructured":"Tanriverdi, O., Barutca, S., & Meydan, N. (2012). Relapse with isolated peritoneal metastasis in lung adenocarcinoma: Case report and review of the literature. Contemporary Oncology (Poznan), 16, 586\u2013589.","journal-title":"Contemporary Oncology (Poznan)"},{"key":"10320_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/ol.2013.1468","volume":"6","author":"M Sereno","year":"2013","unstructured":"Sereno, M., Rodr\u00edguez-Esteban, I., G\u00f3mez-Raposo, C., et al. (2013). Lung cancer and peritoneal carcinomatosis. Oncology Letters, 6, 705\u2013708.","journal-title":"Oncology Letters"},{"key":"10320_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1159\/000366293","volume":"7","author":"A Bazine","year":"2014","unstructured":"Bazine, A., Fetohi, M., Khmamouch, M. R., et al. (2014). An unusual case of isolated peritoneal metastases from lung adenocarcinoma. Case Reports in Oncology, 7, 600\u2013604.","journal-title":"Case Reports in Oncology"},{"key":"10320_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.11604\/pamj.2016.23.60.8910","volume":"23","author":"K Hanane","year":"2016","unstructured":"Hanane, K., Salma, B., Khadija, B., et al. (2016). Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma. The Pan African Medical Journal, 23, 60.","journal-title":"The Pan African Medical Journal"},{"key":"10320_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13256-017-1431-z","volume":"11","author":"P Yang","year":"2017","unstructured":"Yang, P., Li, W. L., Zhou, J. X., et al. (2017). Peritoneum as the sole distant metastatic site of lung adenosquamous cell carcinoma: A case report. Journal of Medical Case Reports, 11, 274.","journal-title":"Journal of Medical Case Reports"},{"key":"10320_CR24","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ejso.2018.07.049","volume":"44","author":"M Flanagan","year":"2018","unstructured":"Flanagan, M., Solon, J., Chang, K., et al. (2018). Peritoneal metastases from extraabdominal cancer: A population-based study. European Journal of Surgical Oncology, 44, 1811\u20131817.","journal-title":"European Journal of Surgical Oncology"},{"key":"10320_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10585-021-10085-z","volume":"38","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink, R. J., Rijken, A., Bakkers, C., et al. (2021). Synchronous peritoneal metastases from lung cancer: Incidence, associated factors, treatment and survival: A Dutch population-based study. Clinical & Experimental Metastasis, 38, 295\u2013303.","journal-title":"Clinical & Experimental Metastasis"},{"key":"10320_CR26","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.2147\/CMAR.S330103","volume":"13","author":"T Tani","year":"2021","unstructured":"Tani, T., Nakachi, I., Ikemura, S., et al. (2021). Clinical characteristics and therapeutic outcomes of metastatic peritoneal carcinomatosis in non-small-cell lung cancer. Cancer Manag Res., 13, 7497\u20137503.","journal-title":"Cancer Manag Res."},{"key":"10320_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2217\/fon-2018-0469","volume":"15","author":"MI Abbate","year":"2019","unstructured":"Abbate, M. I., Cortinovis, D. L., Tiseo, M., et al. (2019). Peritoneal carcinomatosis in non-small-cell lung cancer: Retrospective multicentric analysis and literature review. Future Oncology, 15, 989\u2013994.","journal-title":"Future Oncology"},{"key":"10320_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lungcan.2016.03.007","volume":"96","author":"T Patil","year":"2016","unstructured":"Patil, T., Aisner, D. L., Noonan, S. A., et al. (2016). Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer, 96, 27\u201332.","journal-title":"Lung Cancer"},{"key":"10320_CR29","first-page":"349","volume":"54","author":"A Yoshimoto","year":"2006","unstructured":"Yoshimoto, A., Kasahara, K., Kawashima, A., et al. (2006). Lung cancer with peritoneal carcinomatosis. Lung Cancer, 54, 349\u2013350.","journal-title":"Lung Cancer"},{"key":"10320_CR30","first-page":"1","volume":"73","author":"WP Ceelen","year":"2013","unstructured":"Ceelen, W. P., & Levine, E. A. (2013). Intraperitoneal therapy for peritoneal carcinomatosis: Pharmacologic principles and clinical practice. Drugs, 73, 1\u201317.","journal-title":"Drugs"},{"key":"10320_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JTO.0b013e318219ac78","volume":"6","author":"K Tsuta","year":"2011","unstructured":"Tsuta, K., Kawago, M., Inoue, E., et al. (2011). The prognostic significance of histologic subtypes in lung adenocarcinoma: A proposal for a new classification. Journal of Thoracic Oncology, 6, 469\u2013475.","journal-title":"Journal of Thoracic Oncology"},{"key":"10320_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y. J., Jackson, R. A., & Thiery, J. P. (2016). EMT: 2016. Cell, 166, 21\u201345.","journal-title":"Cell"},{"key":"10320_CR33","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/cancers11101525","volume":"11","author":"A Ito","year":"2019","unstructured":"Ito, A., et al. (2019). Adhesion molecules and metastatic patterns in lung cancer. Cancers (Basel), 11, 1525.","journal-title":"Cancers (Basel)"},{"key":"10320_CR34","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s12253-019-00713-1","volume":"26","author":"H Nassereddine","year":"2020","unstructured":"Nassereddine, H., Sannier, A., Brosseau, S., et al. (2020). Clinicopathological and molecular study of peritoneal carcinomatosis associated with non-small cell lung carcinoma. Pathology Oncology Research, 26, 2795\u20132800.","journal-title":"Pathology Oncology Research"},{"key":"10320_CR35","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2147\/CMAR.S542123","volume":"17","author":"R Ohta","year":"2025","unstructured":"Ohta, R., Ryu, Y., Tanaka, K., Sano, C., & Hayashi, H. (2025). Peritoneal metastasis in non-small cell lung cancer: A systematic review of clinical features, molecular profiles, diagnostic approaches, and outcomes. Cancer Management and Research, 17, 2127\u20132141. https:\/\/doi.org\/10.2147\/CMAR.S542123","journal-title":"Cancer Management and Research"},{"key":"10320_CR36","doi-asserted-by":"publisher","first-page":"e00197","DOI":"10.1002\/rcr2.197","volume":"4","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi, H., Wakuda, K., & Takahashi, T. (2016). Effectiveness of afatinib in lung cancer with paralytic ileus due to peritoneal carcinomatosis. Respirology Case Reports, 4, e00197.","journal-title":"Respirology Case Reports"},{"key":"10320_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","volume":"57","author":"JY Hong","year":"2007","unstructured":"Hong, J. Y., et al. (2007). Peritoneal carcinomatosis in patients with non-small-cell lung cancer: Clinical characteristics and outcome. Lung Cancer, 57, 89\u201393.","journal-title":"Lung Cancer"},{"key":"10320_CR38","first-page":"758","volume":"9","author":"SY Kim","year":"2018","unstructured":"Kim, S. Y., et al. (2018). Clinical outcomes of lung cancer with peritoneal metastasis. Thorac Cancer, 9, 758\u2013764.","journal-title":"Thorac Cancer"},{"key":"10320_CR39","first-page":"1","volume":"12","author":"F Cappuzzo","year":"2020","unstructured":"Cappuzzo, F., et al. (2020). NSCLC with atypical metastatic sites: Clinical management and emerging options. Ther Adv Med Oncol, 12, 1\u201315.","journal-title":"Ther Adv Med Oncol"},{"key":"10320_CR40","first-page":"54","volume":"25","author":"HJ Kim","year":"2010","unstructured":"Kim, H. J., Park, C. M., Koh, J. M., et al. (2010). Peritoneal carcinomatosis from lung cancer: CT findings and clinical features. Journal of Thoracic Imaging, 25, 54\u201358.","journal-title":"Journal of Thoracic Imaging"},{"key":"10320_CR41","first-page":"1113","volume":"31","author":"V Raptopoulos","year":"1993","unstructured":"Raptopoulos, V., et al. (1993). CT of peritoneal carcinomatosis. Radiologic Clinics of North America, 31, 1113\u20131129.","journal-title":"Radiologic Clinics of North America"},{"key":"10320_CR42","first-page":"915","volume":"28","author":"M Nishino","year":"2008","unstructured":"Nishino, M., Kim, H. T., & Shepard, J. A. (2008). CT manifestations of pleural and peritoneal metastases from lung cancer. Radiographics, 28, 915\u2013929.","journal-title":"Radiographics"},{"key":"10320_CR43","first-page":"324","volume":"43","author":"M Calandri","year":"2018","unstructured":"Calandri, M., et al. (2018). PET\/CT in evaluating peritoneal carcinomatosis: Value and limitations. Abdom Radiol (NY), 43, 324\u2013336.","journal-title":"Abdom Radiol (NY)"},{"key":"10320_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/0972-3919.202239","volume":"32","author":"KK Kamaleshwaran","year":"2017","unstructured":"Kamaleshwaran, K. K., Joseph, J., Kalarikal, R. K., & Shinto, A. (2017). Image findings of rare case of peritoneal carcinomatosis from non-small cell lung cancer and response to erlotinib in F-18 FDG positron emission tomography\/computed tomography. Indian Journal of Nuclear Medicine\u202f: IJNM, 32, 140\u2013142.","journal-title":"Indian Journal of Nuclear Medicine : IJNM"},{"key":"10320_CR45","first-page":"319","volume":"25","author":"BA Runyon","year":"1996","unstructured":"Runyon, B. A. (1996). Ascitic fluid cytology in the diagnosis of peritoneal carcinomatosis. Gastroenterology Clinics of North America, 25, 319\u2013332.","journal-title":"Gastroenterology Clinics of North America"},{"key":"10320_CR46","first-page":"639","volume":"267","author":"BA Runyon","year":"1992","unstructured":"Runyon, B. A. (1992). Management of adult patients with ascites due to cirrhosis: An update. JAMA, 267, 639\u2013643.","journal-title":"JAMA"},{"key":"10320_CR47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-012-1319-7","volume":"461","author":"G Pelosi","year":"2012","unstructured":"Pelosi, G., et al. (2012). Markers for diagnosis and characterization of lung adenocarcinoma: TTF-1, napsin A, surfactant proteins, CK7, CK20, CDX2 and others. Virchows Archiv, 461, 495\u2013504.","journal-title":"Virchows Archiv"},{"key":"10320_CR48","first-page":"E881","volume":"9","author":"CH Lin","year":"2017","unstructured":"Lin, C. H., et al. (2017). Peritoneal carcinomatosis in ALK-rearranged non-small-cell lung cancer. Journal of Thoracic Disease, 9, E881\u2013E884.","journal-title":"Journal of Thoracic Disease"},{"key":"10320_CR49","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2147\/OTT.S375246","volume":"15","author":"Y Yagami","year":"2022","unstructured":"Yagami, Y., Nakahara, Y., Manabe, H., et al. (2022). Promising response to dabrafenib plus trametinib in a patient with peritoneal carcinomatosis from non-small-cell lung cancer harboring BRAF V600E mutation. Oncotargets and Therapy, 15, 1369\u20131374.","journal-title":"Oncotargets and Therapy"},{"key":"10320_CR50","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00464-011-2044-z","volume":"26","author":"S Renaud","year":"2012","unstructured":"Renaud, S., Falcoz, P. E., Schaeffer, M., et al. (2012). Video-assisted thoracoscopic and laparoscopic approaches to cancer staging. Surgical Endoscopy, 26, 1382\u20131390.","journal-title":"Surgical Endoscopy"},{"key":"10320_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-016-2169-5","volume":"16","author":"FY Niu","year":"2016","unstructured":"Niu, F. Y., Zhou, Q., Yang, J. J., et al. (2016). Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer, 16, 149.","journal-title":"BMC Cancer"},{"key":"10320_CR52","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler, A., et al. (2006). Paclitaxel\u2013carboplatin alone or with bevacizumab for non\u2013small-cell lung cancer. The New England Journal of Medicine, 355, 2542\u20132550.","journal-title":"The New England Journal of Medicine"},{"key":"10320_CR53","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M., et al. (2016). Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer. New England Journal of Medicine, 375, 1823\u20131833.","journal-title":"New England Journal of Medicine"},{"key":"10320_CR54","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"EB Garon","year":"2015","unstructured":"Garon, E. B., Rizvi, N. A., Hui, R., et al. (2015). Pembrolizumab for the treatment of non\u2013small-cell lung cancer. The New England Journal of Medicine, 372, 2018\u20132028.","journal-title":"The New England Journal of Medicine"},{"key":"10320_CR55","first-page":"101577","volume":"35","author":"R Ikeda","year":"2022","unstructured":"Ikeda, R., et al. (2022). A case of advanced NSCLC with peritoneal metastasis responding to pembrolizumab. Respiratory Medicine Case Reports, 35, 101577.","journal-title":"Respiratory Medicine Case Reports"},{"key":"10320_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13256-019-2178-5","volume":"13","author":"S Sibio","year":"2019","unstructured":"Sibio, S., Sica, G. S., Di Carlo, S., et al. (2019). Surgical treatment of intraperitoneal metastases from lung cancer: Two case reports and a review of the literature. Journal of Medical Case Reports, 13, 262.","journal-title":"Journal of Medical Case Reports"},{"key":"10320_CR57","first-page":"121","volume":"149","author":"HY Lee","year":"2020","unstructured":"Lee, H. Y., Lee, H. Y., Ahn, M. J., et al. (2020). Osimertinib efficacy in EGFR-mutant non-small cell lung cancer with atypical metastases. Lung Cancer, 149, 121\u2013128.","journal-title":"Lung Cancer"},{"key":"10320_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam, S. S., et al. (2020). Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer. New England Journal of Medicine, 382, 41\u201350.","journal-title":"New England Journal of Medicine"},{"key":"10320_CR59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12885-023-10829-y","volume":"23","author":"G Gadaleta-Caldarola","year":"2023","unstructured":"Gadaleta-Caldarola, G., et al. (2023). Long-term response to osimertinib in EGFR-mutated NSCLC with peritoneal involvement. BMC Cancer, 23, 344.","journal-title":"BMC Cancer"},{"key":"10320_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ccr3.2645","volume":"8","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi, Y., Hanaoka, J., Hayashi, H., et al. (2019). Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis. Clin Case Rep., 8, 347\u2013350.","journal-title":"Clin Case Rep."},{"key":"10320_CR61","doi-asserted-by":"publisher","first-page":"1423520","DOI":"10.3389\/fonc.2025.1423520","volume":"15","author":"T Tan","year":"2025","unstructured":"Tan, T., Huang, Y., Yan, R., & Liu, Y. (2025). Case report: Peritoneal and small bowel metastasis from lung adenocarcinoma with EGFR L858R mutation. Frontiers in Oncology, 15, 1423520.","journal-title":"Frontiers in Oncology"},{"key":"10320_CR62","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1056\/NEJMoa1810171","volume":"379","author":"DR Camidge","year":"2018","unstructured":"Camidge, D. R., Kim, H. R., Ahn, M. J., et al. (2018). Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer. New England Journal of Medicine, 379, 2027\u20132039.","journal-title":"New England Journal of Medicine"},{"key":"10320_CR63","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S1470-2045(17)30608-3","volume":"18","author":"YL Wu","year":"2017","unstructured":"Wu, Y. L., et al. (2017). Afatinib versus gefitinib as first-line treatment for EGFRm+ NSCLC: Real-world data. The lancet Oncology, 18, 1454\u20131466.","journal-title":"The lancet Oncology"},{"key":"10320_CR64","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jtho.2019.03.007","volume":"14","author":"DR Camidge","year":"2019","unstructured":"Camidge, D. R., et al. (2019). Updated efficacy and safety data from the global phase III ALEX study of alectinib vs crizotinib in untreated ALK-positive NSCLC. Journal of Thoracic Oncology, 14, 1233\u20131243.","journal-title":"Journal of Thoracic Oncology"},{"key":"10320_CR65","doi-asserted-by":"publisher","first-page":"e233864","DOI":"10.1136\/bcr-2019-233864","volume":"13","author":"V Kazakova","year":"2020","unstructured":"Kazakova, V., Velasco, S. V. A., Perepletchikov, A., et al. (2020). ROS1-rearranged lung adenocarcinoma with peritoneal carcinomatosis on initial presentation. BML Case Reports, 13, e233864.","journal-title":"BML Case Reports"},{"key":"10320_CR66","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00432-020-03262-2","volume":"146","author":"A Aarnink","year":"2020","unstructured":"Aarnink, A., et al. (2020). Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy in patients with non-small cell lung cancer: Real world data from a large cohort in France. Journal of Cancer Research and Clinical Oncology, 146, 2699\u20132707.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10320_CR67","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon, B. A. (2009). Management of adult patients with ascites due to cirrhosis: An update. Hepatology, 49, 2087\u20132107.","journal-title":"Hepatology"},{"key":"10320_CR68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cas.15630","volume":"114","author":"T Ishikawa","year":"2023","unstructured":"Ishikawa, T., et al. (2023). Experimental approaches for peritoneal metastases in lung cancer. Cancer Science, 114, 78\u201385.","journal-title":"Cancer Science"},{"key":"10320_CR69","first-page":"218","volume":"15","author":"PH Sugarbaker","year":"2009","unstructured":"Sugarbaker, P. H. (2009). Intraperitoneal chemotherapy and cytoreductive surgery for the treatment of peritoneal carcinomatosis: A review. Cancer Journal, 15, 218\u2013224.","journal-title":"Cancer Journal"},{"key":"10320_CR70","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00595-020-02180-7","volume":"51","author":"T Kitai","year":"2020","unstructured":"Kitai, T. (2020). The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: A systematic review including evidence from Japan. Surgery Today, 51, 1085\u20131098.","journal-title":"Surgery Today"},{"key":"10320_CR71","first-page":"243","volume":"108","author":"G Passot","year":"2013","unstructured":"Passot, G., & Glehen, O. (2013). How to select patients for cytoreductive surgery and HIPEC in colorectal carcinomatosis. Journal of Surgical Oncology, 108, 243\u2013246.","journal-title":"Journal of Surgical Oncology"},{"key":"10320_CR72","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net, F., Elias, D., Roca, L., et al. (2021). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): A multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 22, 256\u2013266.","journal-title":"Lancet Oncology"},{"key":"10320_CR73","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/1752-1947-2-372","volume":"2","author":"H Kimura","year":"2008","unstructured":"Kimura, H., Iizasa, T., Ishikawa, A., et al. (2008). Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: A case report. Journal of Medical Case Reports, 2, 372.","journal-title":"Journal of Medical Case Reports"},{"key":"10320_CR74","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3892\/ol.2014.2169","volume":"8","author":"B Li","year":"2014","unstructured":"Li, B., Lu, J. C., He, D., et al. (2014). Rapid onset lung squamous cell carcinoma with prominent peritoneal carcinomatosis and an eosinophilic leukemoid reaction, with coexistence of the BRAF V600E and oncogenic KRAS G12A mutations: A case report. Oncology Letters, 8, 589\u2013593.","journal-title":"Oncology Letters"},{"key":"10320_CR75","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13256-017-1431-z","volume":"11","author":"P Yang","year":"2017","unstructured":"Yang, P., Li, W. L., Zhou, J. X., et al. (2017). Peritoneum as the sole distant metastatic site of lung adenosquamous cell carcinoma: A case report. J Med Case Rep, 11, 274.","journal-title":"J Med Case Rep"},{"key":"10320_CR76","first-page":"e126","volume":"15","author":"JF Hsu","year":"2019","unstructured":"Hsu, J. F., Lee, Y. L., Chang, H. L., et al. (2019). Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung. Asia-Pacific Journal Clinic Oncoogy, 15, e126\u2013e131.","journal-title":"Asia-Pacific Journal Clinic Oncoogy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10320-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:05:59Z","timestamp":1771538759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10320-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["10320"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10320-7","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"8"}}